For the aforementioned histone modifications, EZH2 overexpression has been found to lead to AR silencing in AR-indifferent PCa, transdifferentiation from adenocarcinoma to NEPC, and the activation of lineage-plasticity-related factors [169,170]. Here, AR is linked to adenocarcinoma.